NEWS AND COMMENTARY

Overturning Chevron: What It Means for Cannabis Rescheduling
by Keegan Gendron | Jul 31, 2024 | Blogs
In June of this year, the Supreme Court’s ruling on Loper Bright Enterprises v. Raimondo and Relentless, Inc. v. Department of Commerce effectively resulted in the overturning of the famous “Chevron” decision, a 40+ year old precedent that has proven foundational to...
BASIS FOR THE RECOMMENDATION TO RESCHEDULE MARIJUANA INTO SCHEDULE III OF THE CONTROLLED SUBSTANCES ACT
by Hannah Boyum | Jun 11, 2024 | Media, News
This document incorporates research conducted by Cannabis Public Policy Consulting.
Innovating in Cannabis policy
by Mackenzie Slade | Jun 11, 2024 | In the Press, Media, News
Since 2012, adult use Cannabis legalization has arisen as one of the America’s greatest social experiments. Serving as the catalyst to a newfound awareness of the limitations of federalism, the state-confined legalization of Cannabis is an innovation in public policy. Before beginning to identify avenues that further innovate Cannabis policy, we must start with this premise: that a regulatory infrastructure tailored to create a limited yet inclusive economy with a federally illicit controlled substance is intrinsically innovative. As with all innovative policies, diffusion across jurisdictions has become rampant. In the 10-year period from the “birth year” of Cannabis legalization for adult consumers to the year of preparing this chapter, 22 states have legalized Cannabis for adult use. In this same timeframe, 23 states legalized Cannabis for medical consumers,
leading to a total of 38 states with a form of legalized Cannabis. Many of these states are overlapping, suggesting that the liberalization of Cannabis policies within jurisdictions has also been seen with urgency.

Making Sense of Schedule III: Debunking Common Misunderstandings About Cannabis Rescheduling
by Summer Fox | May 28, 2024 | Blogs
In a move touted by President Biden as “monumental,” the Drug Enforcement Administration (DEA) has officially made a formal recommendation to move cannabis from Schedule I to Schedule III of the Controlled Substances Act and submitted a notice of proposed rulemaking...

Three Actionable Ways States Can Prepare for Federal Cannabis Legalization
by Summer Fox | Apr 25, 2024 | Blogs
It’s becoming increasingly clear that changes to America’s federal cannabis laws are all but inevitable. What’s a bit hazier, however, is what those changes will actually look like and when those changes will take place. Whether the cannabis floodgates open in a...

10 Years After the World’s First Legal Sale of Cannabis, What Have We Learned?
by Keegan Gendron | Jan 11, 2024 | Blogs

Regulation, prevalence and impacts of cannabis consumption in the US – Podcast
by Cannabis Public Policy Consulting | Sep 28, 2022 | Media
https://researchpod.org/education-training/regulation-prevalence-and-impacts-of-cannabis-consumption-in-the-us

Maryland Medical Cannabis Commission Receives Unprecedented Response to its 1st Medical Cannabis Patient Survey
by Cannabis Public Policy Consulting | Sep 22, 2022 | Press Releases
FOR IMMEDIATE RELEASE Media Contact: Dawn Berkowitz, Deputy Executive Director, dawn.berkowitz@maryland.gov, 410-487-8075 David Torres, Communications Director, david.torres@maryland.gov or 410-487-8050 Maryland Medical Cannabis Commission Receives Unprecedented...

CannabisRadio: Blunt Business
by Cannabis Public Policy Consulting | Sep 15, 2022 | Media

Cannabis Public Policy Consulting Launches Regulatory Determinants of Cannabis Outcomes Survey
by Cannabis Public Policy Consulting | Sep 12, 2022 | Press Releases
FOR IMMEDIATE RELEASE Contact: Adrienne Uthe, Kronus Communications mobile: +1 [715] 418-1614 adrienne.uthe@kronuscommunications.com Quarterly Assessment Is Largest and Most Comprehensive Research To Date On Cannabis Trends Sudbury, MA (June 6, 2022) – Cannabis Public...
STAY INFORMED ON CPPC'S RESEARCH AND PROJECTS